Boehringer Ingelheim’s asthma drug wins FDA approval – Danbury News Times


Danbury News Times

Boehringer Ingelheim's asthma drug wins FDA approval
Danbury News Times
DANBURY — Nearly one in 10 adults in Connecticut – 9.2 percent – has asthma. Boehringer Ingelheim, the Danbury-based pharmaceutical company cited the figure as it announced the federally approved availability of its new Spiriva Respimat product for …
Spiriva Respimat Now Available in Pharmacies for Asthma PatientsPharmacy Times

all 3 news articles »

View full post on asthma – Google News

Cat allergy group Circassia wins approval for asthma drug – Telegraph.co.uk


Telegraph.co.uk

Cat allergy group Circassia wins approval for asthma drug
Telegraph.co.uk
Cat allergy group Circassia wins approval for asthma drug. The inhaler will soon be available to European consumers as a generic alternative to rival a treatment already on the market from GlaxoSmithKline. Grumpycat. Circassia is developing a novel …
Industry NewsCircassia wins EU asthma product approvalIFA Magazine
Circassia wins EU regulatory boost for asthma generic drugYahoo Finance UK
Circassia Pharma gets UK approval for asthma challengerProactive Investors UK

all 13 news articles »

View full post on asthma – Google News

U Team Wins Grant to Develop Research on Childhood Asthma – Daily Utah Chronicle


Daily Utah Chronicle

U Team Wins Grant to Develop Research on Childhood Asthma
Daily Utah Chronicle
The National Institutes of Health awarded a U team a $5.5 million grant to design a system that will be used to study pediatric asthma. The team will develop the infrastructure over the next year based on input from medical faculty and patient families.

View full post on asthma – Google News

Glaxos Eosinophilic Asthma Drug Nucala Wins CHMP Backing – Zacks.com


BioPharma Dive

Glaxos Eosinophilic Asthma Drug Nucala Wins CHMP Backing
Zacks.com
In the U.S., the drug is approved for both COPD and asthma. We note that Glaxo has a collaboration agreement with Theravance for Relvar/Breo Ellipta and Anoro Ellipta (COPD). Relvar/Breo Ellipta generated sales of £94 million in the first half of 2015.
After bad news on Breo, Glaxo's monthly asthma drug wins an EU recBioPharma Dive

all 2 news articles »

View full post on asthma – Google News

Jacksonville Researcher Wins Award For Study On Asthma In African American … – WJCT NEWS


WJCT NEWS

Jacksonville Researcher Wins Award For Study On Asthma In African American
WJCT NEWS
A faculty member from Jacksonville's Edward Waters College, won an award last Friday for his medical research on asthma and allergies affecting African Americans. The Historically Black College or University Awards presented Dr. Brian Seymour with the …

View full post on asthma – Google News

Teva’s DuoResp Spiromax For Asthma, COPD Wins Medical Design Award – Lung Disease News


Lung Disease News

Teva's DuoResp Spiromax For Asthma, COPD Wins Medical Design Award
Lung Disease News
We are incredibly proud to be leading the way in providing people with asthma and COPD with inhalers that recognize and support their needs and long term health, and are delighted with this prestigious acknowledgment for DuoResp Spiromax,” noted Rob …

View full post on asthma – Google News

Nurtur’s Asthma Management Program Wins Award from Dorland Health – PR Newswire (press release)

Nurtur's Asthma Management Program Wins Award from Dorland Health
PR Newswire (press release)
FARMINGTON, Conn., May 27, 2015 /PRNewswire/ — Nurtur Health, Inc. (Nurtur), a wholly owned subsidiary of Centene Corporation (NYSE: CNC), was recently honored by Dorland Health's Case in Point Platinum Awards for its innovative Asthma …

and more »

View full post on asthma – Google News